Benzimidazole compound and pharmaceutical use thereof
申请人:Nakano Masakazu
公开号:US08877779B2
公开(公告)日:2014-11-04
Provided is an ORL-1 receptor agonist having improved bioavailability based on superior metabolic stability and strong and high selectivity, as compared to conventional compounds. A compound represented by the formula (I)
wherein each symbol is as defined in the claims.